These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6852993)

  • 21. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
    DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
    Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of amiodarone in the treatment of ventricular tachycardia or ventricular fibrillation.
    Greene HL
    Prog Cardiovasc Dis; 1989; 31(5):319-54. PubMed ID: 2646655
    [No Abstract]   [Full Text] [Related]  

  • 23. [Amiodarone in ventricular tachycardias].
    Steinbeck G; Manz M; Lüderitz B
    MMW Munch Med Wochenschr; 1982 Aug; 124(34):723-7. PubMed ID: 6813695
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
    Best JF; Rinkenberger R; Lynch L; Dunn M
    Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone for ventricular arrhythmias.
    N Engl J Med; 1981 Dec; 305(26):1587-9. PubMed ID: 7312002
    [No Abstract]   [Full Text] [Related]  

  • 27. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR; Loogen F
    Eur Heart J; 1980 Feb; 1(1):11-24. PubMed ID: 7026245
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiodarone for refractory automatic atrial tachycardia: observations on the electrophysiological actions of amiodarone.
    Wiener I; Lyons H
    Pacing Clin Electrophysiol; 1984 Jul; 7(4):707-9. PubMed ID: 6205373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone.
    Somberg JC
    Am J Cardiol; 1987 Nov; 60(14):1218. PubMed ID: 3687772
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
    Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
    Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
    Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone--an investigative drug in the coronary care unit.
    Valladares BK; Lemberg L
    Heart Lung; 1983 May; 12(3):325-8. PubMed ID: 6551384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of amiodarone on retrograde conduction and refractoriness of the His-Purkinje system in man.
    Reddy CP; Kuo CS
    Br Heart J; 1984 Jun; 51(6):648-53. PubMed ID: 6732994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
    Naccarelli GV; Fineberg NS; Zipes DP; Heger JJ; Duncan G; Prystowsky EN
    J Am Coll Cardiol; 1985 Oct; 6(4):814-21. PubMed ID: 3928727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Amiodarone, an anti-arrhythmic agent (apropos of a case of ventricular recurrent tachycardia in a coronary patient)].
    Husson J
    Lille Med; 1975 Feb; 20(2):109-12. PubMed ID: 1142986
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.